Development in self-reported arm-lymphedema in Danish women treated for early-stage breast cancer in 2005 and 2006 - A nationwide follow-up study

Breast

Volumn 23, Issue 4, 2014, Pages 445-452

  Gärtner, Rune ^a   Mejdahl, Mathias Kvist ^a   Andersen, Kenneth Geving ^a   Ewertz, Marianne ^b   Kroman, Niels ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Associated factors; Breast cancer; Development; Lymphedema; Prevalence

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CONTROLLED STUDY; DENMARK; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; LYMPHEDEMA; MAJOR CLINICAL STUDY; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; PARTIAL MASTECTOMY; PATIENT ASSESSMENT; PRIORITY JOURNAL; SELF REPORT; SENTINEL LYMPH NODE BIOPSY; SYMPTOM; YOUNG ADULT; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADOLESCENT; ARM; BREAST NEOPLASMS; MASTECTOMY; PATHOLOGY; PREVALENCE; SEGMENTAL MASTECTOMY; SEVERITY OF ILLNESS INDEX; STATISTICS;

ADOLESCENT; ADULT; AGED; ARM; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DENMARK; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPHEDEMA; MASTECTOMY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM STAGING; PREVALENCE; RADIOTHERAPY, ADJUVANT; SELF REPORT; SENTINEL LYMPH NODE BIOPSY; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC; YOUNG ADULT;

EID: 84902549418     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2014.03.001     Document Type: Article

References (39)

1. 2013. http://seer.cancer.gov/statfacts/html/breast.html#prevalence.
2. Gärtner R., Jensen M.B., Kronborg L., Ewertz M., Kehlet H., Kroman N. Self-reported arm-lymphedema and functional impairment after breast cancer treatment-a nationwide study of prevalence and associated factors. Breast 2010, 19(6):506-515.
3. Ahmed R.L., Prizment A., Lazovich D., Schmitz K.H., Folsom A.R. Lymphedema and quality of life in breast cancer survivors: the Iowa Women's Health Study. JClin Oncol 2008, 26(35):5689-5696.
4. Hayes S.C., Janda M., Cornish B., Battistutta D., Newman B. Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function. JClin Oncol 2008, 26(21):3536-3542.
5. Ridner S.H., Bonner C.M., Deng J., Sinclair V.G. Voices from the shadows: living with lymphedema. Cancer Nurs 2012, 35(1):E18-E26.
6. McWayne J., Heiney S.P. Psychologic and social sequelae of secondary lymphedema: a review. Cancer 2005, 104(3):457-466.
7. Vassard D., Olsen M.H., Zinckernagel L., Vibe-Petersen J., Dalton S.O., Johansen C. Psychological consequences of lymphoedema associated with breast cancer: a prospective cohort study. Eur J Cancer 2010, 46(18):3211-3218.
8. Bell R.J., Robinson P.J., Barallon R., Fradkin P., Schwarz M., Davis S.R. Lymphedema: experience of a cohort of women with breast cancer followed for 4 years after diagnosis in Victoria, Australia. Support Care Cancer 2013, 21(7):2017-2024.
9. Fu M.R., Ridner S.H., Hu S.H., Stewart B.R., Cormier J.N., Armer J.M. Psychosocial impact of lymphedema: a systematic review of literature from 2004 to 2011. Psychooncology 2013, 22(7):1466-1484.
10. Paskett E.D., Dean J.A., Oliveri J.M., Harrop J.P. Cancer-related lymphedema risk factors, diagnosis, treatment, and impact: a review. JClin Oncol 2012, 30(30):3726-3733.
11. Tsai R.J., Dennis L.K., Lynch C.F., Snetselaar L.G., Zamba G.K., Scott-Conner C. The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors. Ann Surg Oncol 2009, 16(7):1959-1972.
12. Yen T.W., Fan X., Sparapani R., Laud P.W., Walker A.P., Nattinger A.B. Acontemporary, population-based study of lymphedema risk factors in older women with breast cancer. Ann Surg Oncol 2009, 16(4):979-988.
13. Mortimer P.S. The pathophysiology of lymphedema. Cancer 1998, 83(12 Suppl.American):2798-2802.
14. Warren A.G., Brorson H., Borud L.J., Slavin S.A. Lymphedema: a comprehensive review. Ann Plast Surg 2007, 59(4):464-472.
15. Armer J.M., Radina M.E., Porock D., Culbertson S.D. Predicting breast cancer-related lymphedema using self-reported symptoms. Nurs Res 2003, 52(6):370-379.
16. Shah C., Vicini F.A. Breast cancer-related arm lymphedema: incidence rates, diagnostic techniques, optimal management and risk reduction strategies. Int J Radiat Oncol Biol Phys 2011, 81(4):907-914.
17. DiSipio T., Rye S., Newman B., Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol 2013, 14(6):500-515.
18. Herd-Smith A., Russo A., Muraca M.G., Del Turco M.R., Cardona G. Prognostic factors for lymphedema after primary treatment of breast carcinoma. Cancer 2001, 92(7):1783-1787.
19. Petrek J.A., Senie R.T., Peters M., Rosen P.P. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer 2001, 92(6):1368-1377.
20. Norman S.A., Localio A.R., Potashnik S.L., Simoes Torpey H.A., Kallan M.J., Weber A.L., et al. Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms. JClin Oncol 2009, 27(3):390-397.
21. Paskett E.D., Naughton M.J., McCoy T.P., Case L.D., Abbott J.M. The epidemiology of arm and hand swelling in premenopausal breast cancer survivors. Cancer Epidemiol Biomarkers Prev 2007, 16(4):775-782.
22. Gärtner R., Jensen M.B., Nielsen J., Ewertz M., Kroman N., Kehlet H. Prevalence of and factors associated with persistent pain following breast cancer surgery. JAMA 2009, 302(18):1985-1992.
23. Mejdahl M.K., Andersen K.G., Gartner R., Kroman N., Kehlet H. Persistent pain and sensory disturbances after treatment for breast cancer: six year nationwide follow-up study. BMJ 2013, 346:f1865.
24. Blichert-Toft M., Christiansen P., Mouridsen H.T. Danish Breast Cancer Cooperative Group-DBCG: history, organization, and status of scientific achievements at 30-year anniversary. Acta Oncol 2008, 47(4):497-505.
25. Møller S., Jensen M.B., Ejlertsen B., Bjerre K.D., Larsen M., Hansen H.B., et al. The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise. Acta Oncol 2008, 47(4):506-524.
26. Bender R., Kuss O., Hildebrandt M., Gehrmann U. Estimating adjusted NNT measures in logistic regression analysis. Stat Med 2007, 26(30):5586-5595.
27. Erickson V.S., Pearson M.L., Ganz P.A., Adams J., Kahn K.L. Arm edema in breast cancer patients. JNatl Cancer Inst 2001, 93(2):96-111.
28. Ancukiewicz M., Miller C.L., Skolny M.N., O'Toole J., Warren L.E., Jammallo L.S., et al. Comparison of relative versus absolute arm size change as criteria for quantifying breast cancer-related lymphedema: the flaws in current studies and need for universal methodology. Breast Cancer Res Treat 2012, 135(1):145-152.
29. Armer J.M., Stewart B.R. Acomparison of four diagnostic criteria for lymphedema in a post-breast cancer population. Lymphat Res Biol 2005, 3(4):208-217.
30. Norman S.A., Miller L.T., Erikson H.B., Norman M.F., McCorkle R. Development and validation of a telephone questionnaire to characterize lymphedema in women treated for breast cancer. Phys Ther 2001, 81(6):1192-1205.
31. Hayes S., Janda M., Cornish B., Battistutta D., Newman B. Lymphedema secondary to breast cancer: how choice of measure influences diagnosis, prevalence, and identifiable risk factors. Lymphology 2008, 41(1):18-28.
32. Czerniec S.A., Ward L.C., Refshauge K.M., Beith J., Lee M.J., York S., et al. Assessment of breast cancer-related arm lymphedema-comparison of physical measurement methods and self-report. Cancer Invest 2010, 28(1):54-62.
33. McLaughlin S.A., Wright M.J., Morris K.T., Giron G.L., Sampson M.R., Brockway J.P., et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. JClin Oncol 2008, 26(32):5213-5219.
34. Bar Ad V., Dutta P.R., Solin L.J., Hwang W.T., Tan K.S., Both S., et al. Time-course of arm lymphedema and potential risk factors for progression of lymphedema after breast conservation treatment for early stage breast cancer. Breast J 2012, 18(3):219-225.
35. Stamatakos M., Stefanaki C., Kontzoglou K. Lymphedema and breast cancer: a review of the literature. Breast Cancer 2011, 18(3):174-180.
36. Jammallo L.S., Miller C.L., Singer M., Horick N.K., Skolny M.N., Specht M.C., et al. Impact of body mass index and weight fluctuation on lymphedema riskinpatients treated for breast cancer. Breast Cancer Res Treat 2013, 142(1):59-67.
37. Hayes S.C., Johansson K., Stout N.L., Prosnitz R., Armer J.M., Gabram S., et al. Upper-body morbidity after breast cancer: incidence and evidence for evaluation, prevention, and management within a prospective surveillance model of care. Cancer 2012, 118(8 Suppl.):2237-2249.
38. McCredie M.R., Dite G.S., Porter L., Maskiell J., Giles G.G., Phillips K.A., et al. Prevalence of self-reported arm morbidity following treatment for breast cancer in the Australian Breast Cancer Family Study. Breast 2001, 10(6):515-522.
39. Kiel K.D., Rademacker A.W. Early-stage breast cancer: arm edema after wide excision and breast irradiation. Radiology 1996, 198(1):279-283.